Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911062 · ClinicalTrials.gov registry record · Phase 2
HTX-011 in Spinal Surgery
A Phase 2 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT04911062 is a Phase 2 study that has completed, run by Heron Therapeutics. The registered enrollment target is 32 participants.
The verdict
NCT04911062, a Phase 2 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a Phase 2, multicenter study in subjects undergoing an open lumbar decompression surgery.
Interventions
- DRUG HTX-011
- DEVICE Luer Lock Applicator
- DRUG Bupivacaine HCI without epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-04-07 |
| Est. Completion | 2022-08-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04911062
The ClinicalTrials.gov registry entry for NCT04911062 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heron Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which HTX-011 is the first listed.
NCT04911062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04911062 about?
NCT04911062 is a clinical study titled "HTX-011 in Spinal Surgery". This is a Phase 2, multicenter study in subjects undergoing an open lumbar decompression surgery.
What is the current status of trial NCT04911062?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2022-04-07. Estimated completion is 2022-08-26.
What interventions are being tested in trial NCT04911062?
The interventions under investigation include: HTX-011 (DRUG), Luer Lock Applicator (DEVICE), Bupivacaine HCI without epinephrine (DRUG).
Who is sponsoring clinical trial NCT04911062?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.